Cargando…

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

BACKGROUND: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. OBJECTIVE: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking cabergoline for the treatment of prolactinoma and to ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khare, Shruti, Lila, Anurag R., Patil, Rishikesh, Phadke, Milind, Kerkar, Prafulla, Bandgar, Tushar, Shah, Nalini S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240058/ https://www.ncbi.nlm.nih.gov/pubmed/28217516 http://dx.doi.org/10.4103/2230-8210.196010

Ejemplares similares

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
por: Hayes, Annabelle G, et al.
Publicado: (2022)

Remission in Cushing disease with cabergoline
por: Gopal, Raju, et al.
Publicado: (2008)

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation
por: Yedinak, Chris G., et al.
Publicado: (2014)

The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening
por: Caputo, Carmela, et al.
Publicado: (2018)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Gender differences in macroprolactinomas: a single centre experience
por: Khare, Shruti, et al.
Publicado: (2015)

Spontaneous reduction of prolactinoma post cabergoline withdrawal
por: Venkatesh, Sampath Kumar, et al.
Publicado: (2012)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009)

Promise and pitfalls of molecular markers of thyroid nodules
por: Jadhav, S., et al.
Publicado: (2012)

Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
por: Pala, Nazir A., et al.
Publicado: (2015)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Bilateral adrenal masses: a single-centre experience
por: Lomte, Nilesh, et al.
Publicado: (2016)

Management issues with exogenous steroid therapy
por: Patt, Hiren, et al.
Publicado: (2013)

Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
por: Diwaker, Chakra, et al.
Publicado: (2022)

Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma
por: Doğan, Berçem Ayçiçek, et al.
Publicado: (2016)

Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas
por: Binar, M, et al.
Publicado: (2019)

Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022)

Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?
por: Budyal, Sweta, et al.
Publicado: (2015)

Alveolar Soft Part Sarcoma Presenting as Hypervascular Adrenal Metastasis
por: Goroshi, Manjunath, et al.
Publicado: (2018)

Abstract 70: High dose intravenous therapy augments complete anterior pituitary hormoanl recovery in primary autoimmune hypophysitis
por: Brijesh, K, et al.
Publicado: (2022)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

Comparison of (68)Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome
por: Goroshi, Majunath R, et al.
Publicado: (2016)

Aortoarteritis: Could it be a form of catecholamine-induced vasculitis?
por: Sarathi, Vijaya, et al.
Publicado: (2013)

Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
por: Almistehi, Wael M, et al.
Publicado: (2018)

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Current concepts in blood glucose monitoring
por: Khadilkar, Kranti Shreesh, et al.
Publicado: (2013)

First Trimester Thyroid Function Tests: Normative Data from Western India
por: Nambiar, Vimal M., et al.
Publicado: (2018)

Cytochrome P450 Oxidoreductase Deficiency: Novel Cause of Ambiguity with Primary Amenorrhea
por: Khadilkar, Kranti Shreesh, et al.
Publicado: (2017)

Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline
por: Astaf’eva, Ludmila, et al.
Publicado: (2020)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
por: Belhadj Slimane, Chayma, et al.
Publicado: (2023)

Cor Triatriatum with Partial Atrioventricular Septal Defect
por: Pahwa, Jivtesh S., et al.
Publicado: (2016)

Supratricuspid obstructive membrane in congenitally corrected transposition of the great arteries
por: Kumar, Sanjeev, et al.
Publicado: (2013)

Hypophosphatemic rickets
por: Jagtap, Varsha S., et al.
Publicado: (2012)

Cushing's syndrome: Stepwise approach to diagnosis
por: Lila, Anurag R., et al.
Publicado: (2011)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy
por: Bajwa, Sukhwinder Kaur, et al.
Publicado: (2011)

Cabergoline Effectively Induced Remission of Prolactinoma in a 9-year-old Japanese Boy
por: Sano, Hitomi, et al.
Publicado: (2009)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_au9dh5m70k12esdfko6k0krpin